KLRS
Kalaris Therapeutics

71
Loading...
Loading...
Latest Earnings Results: Q2 '25
Reported: Aug 13

Estimated EPS

-$0.46

Reported EPS

-$0.61

Surprise

-32.61%

Estimated Rev

$0M

Reported Rev

---

Surprise

---

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.61
--
--
N/A
Q2 '25
-$0.46
-$0.61
-32.61%
MISSED
Q1 '25
--
-$2.52
--
N/A

Latest KLRS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.